MnSOD rs4880 and XPD rs13181 polymorphisms predict the survival of breast cancer patients treated with adjuvant tamoxifen. [electronic resource]
Producer: 20150105Description: 769-75 p. digitalISSN:- 1651-226X
- Adult
- Aged
- Antineoplastic Agents, Hormonal -- therapeutic use
- Breast Neoplasms -- drug therapy
- Carcinoma -- drug therapy
- Case-Control Studies
- Chemotherapy, Adjuvant
- Cohort Studies
- Disease-Free Survival
- Female
- Genotype
- Humans
- Kaplan-Meier Estimate
- Middle Aged
- Polymorphism, Single Nucleotide
- Prognosis
- Proportional Hazards Models
- Prospective Studies
- Superoxide Dismutase -- genetics
- Tamoxifen -- therapeutic use
- Xeroderma Pigmentosum Group D Protein -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.